Bielack S, Carrle D, Jost L. Osteosarcoma. ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol. 2008;19(Suppl 2(Suppl 2):ii94–96.
Gross SW. The Classic: sarcoma of the long bones: based upon a study of one hundred and sixty-five cases. 1879. Clin Orthop Relat Res. 2005;438:9–14.
Wan IF, Saad A, Alsaigh LN, Azman M, Zulmi W. Prognostic factors and survival rate of osteosarcoma: a single-institution study. Asia-Pac J Clin Oncol. 2017;13(2):e104–10.
Harris MB, Gieser P, Goorin AM, Ayala A, Shochat SJ, Ferguson WS, et al. Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study. J Clin Oncol. 1998;16(11):3641.
Wu Y, Lei X, Yang P, Nong L, Huang X, Pan W, et al. Survival Prediction in High-grade Osteosarcoma Using Radiomics of Diagnostic Computed Tomography. Ebiomedicine. 2018; S2352396418302457-.
Ouyang Z, Li G, Zhu H, Wang J, Lu Q. Construction of a Five-Super-Enhancer-Associated-Genes Prognostic Model for Osteosarcoma Patients. Front cell Dev biology. 2020;8:598–660.
Yao Z, Tan Z, Yang J, Yang Y, Yang Z. Prognostic Nomogram for Predicting 5-year overall survival in chinese patients with high-grade Osteosarcoma. Sci Rep. 2021;11(1):17728.
Mei Z, Shi L, Wang B, Yang J, Xiao Z, Du P, Wang Q, Yang W. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: a systematic review and meta-analysis of 66 cohort studies. Cancer Treat Rev. 2017;58:1–13.
Kelley LM, Schlegel M, Hecker-Nolting S, Kevric M, Lüttichau I. Pathological fracture and prognosis of High-Grade Osteosarcoma of the Extremities: an analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) patients. J Clin Oncol. 2020;38(8):823–33.
He Y, Liu H, Wang S, Zhang J. A nomogram for predicting cancer-specific survival in patients with osteosarcoma as secondary malignancy. Sci Rep. 2020;10(1):12817.
Chen B, Zeng Y, Liu B, Lu G, Ma J. Risk, Factors. Prognostic factors, and Nomograms for distant metastasis in patients with newly diagnosed Osteosarcoma: a Population-Based study. Front Endocrinol. 2021;12:672024.
Qi L, Ren X, Liu Z, Li S, Zhang W, Chen R, et al. Predictors and survival of patients with Osteosarcoma after Limb Salvage versus Amputation: a Population-Based analysis with propensity score matching. World J Surg. 2020;44(7):2201–10.
Clark J, Dass CR, Choong P. A review of clinical and molecular prognostic factors in osteosarcoma. J Cancer Res Clin Oncol. 2008;134(3):281–97.
Broadhead ML, Clark J, Myers DE, Dass CR, Choong P. The Molecular Pathogenesis of Osteosarcoma: A Review. Sarcoma. 2011; 2011:959248.
Kim SH, Shin KH, Moon SH, Jang J, Yang WI. Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma. Cancer Med. 2017;6(Suppl 1):1311–22.
Yang S, Wu C, Wang L, Shan D, Chen B. Pretreatment inflammatory indexes as prognostic predictors for survival in osteosarcoma patients. Int J Clin Experiment Pathol. 2020;13(3):515.
Jiang M, Ma S, Hua Z, Zhao Z, Gao S. Prognostic Value of Pretreated Blood Inflammatory Markers in Patients with Bone Sarcoma: A Meta-Analysis. Disease Markers. 2021; 2021(1):1–10.
Kattan MW, Eastham JA, Stapleton A, Wheeler TM, Scardino PT. A preoperative Nomogram for Disease Recurrence following radical prostatectomy for prostate Cancer. J Natl Cancer Inst. 1998;90(10):766–71.
Mittendorf EA, Hunt KK, Boughey JC, Bassett R, Degnim AC, Harrell R, et al. Incorporation of Sentinel Lymph Node Metastasis size into a Nomogram Predicting Nonsentinel Lymph Node involvement in breast Cancer patients with a positive Sentinel Lymph Node. Ann Surg. 2012;255(1):109–15.
Valentini V, Stiphout R, Lammering G, Gambacorta MA, Lambin P. Nomograms for predicting local recurrence, distant metastases, and overall survival for patients with locally advanced rectal cancer on the basis of european randomized clinical trials. J Clin Oncol Official J Am Soc Clin Oncol. 2011;29(23):3163.
Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol Official J Am Soc Clin Oncol. 2013;31(9):1188–95.
Luigi M, Rosalba, Miceli M. Kattan, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005;103(2):402–8.
Enneking WF, Spanier SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res. 1980;(153):106–20.
Choi JH, Ro JY. The 2020 WHO Classification of Tumors of Bone: An Updated Review. Adv Anat Pathol. 2021;28(3):119–38.
Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–45.
Zhang M, Liu Y, Kong D. Identifying biomolecules and constructing a prognostic risk prediction model for recurrence in osteosarcoma. J Bone Oncol. 2020;26(11):100331.
Hu C, Liu C, Tian S, Wang Y, Ye L. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients. BMC Cancer. 2020;20(1):1.
Amp L, Werb Z. Review article inflammation and cancer. Nature. 2002;420(6917):860–7.
Ikeda M, Furukawa H, Imamura H, Shimizu J, Satomi T. Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol. 2002;9(3):287–91.
Zhao GF, Hu YH, Liu RL, Shi F, Wang BC. [Clinical significance of the preoperative neutrophil lymphocyte ratio in the evaluation of the prognosis of laryngeal carcinoma]. Chin J Otorhinolaryngol Head Neck Surg. 2016;51(2):112–6.
Tecchio C. Neutrophil-derived cytokines involved in physiological and pathological angiogenesis. Chem Immunol Allergy. 2014;99:123.
Bambace NM, Holmes CE. The platelet contribution to cancer progression. J Thromb Haemost. 2010;9(2):237–49.
Spicer JD, Mcdonald B, Cools-Lartigue JJ, Chow SC, Giannias B, Kubes P, et al. Neutrophils promote liver metastasis via Mac-1-mediated interactions with circulating tumor cells. Cancer Res. 2012;72(16):3919–27.
Mcmillan DC. The systemic inflammation-based Glasgow Prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–40.
Gu X, Sun S, Gao XS, Xiong W, Qin S, Qi X, et al. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients. Rep. 2016;6(1):23893.
Deng Q, He B, Liu X, Yue J, Ying H, Pan Y, et al. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model. J Translational Med. 2015;13(1):1–16.
Yapar A, Tokgz MA, Yapar D, Atalay SB, Gungor BS. Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma. Joint Dis Relat Surg. 2021;32(2):489–96.